Breaking News

Doctors fear prosecution post-Roe; biotech VC deals and valuations begin falling apart

 

Daily Recap

'A scary time': Fear of prosecution forces doctors to choose between protecting themselves or their patients

By Olivia Goldhill

Meg Kinnard/AP

Physicians risk losing their license and potentially prison time if they violate these laws, so doctors and hospitals are taking no chances.

Read More

STAT+: VC deals and valuations begin falling apart amid biotech's stock shock

By Allison DeAngelis

Mike Reddy for STAT

After raking in record amounts of capital over the last two years, VCs are seeing signs that the capital could dry up.

Read More

STAT+: FDA to convene second panel of outside experts to review Amylyx Pharma's ALS treatment

By Adam Feuerstein

Sarah Silbiger/Getty Images

The FDA’s decision to schedule a second advisory panel for the same drug is unusual, particularly during the same review period.

Read More

In a boost for species conservation, freeze-dried mouse cells produce healthy pups

By Megan Molteni

University of Yamanashi

Somatic cells — not just sperm or eggs — can be used to clone healthy mice, even after being freeze-dried and stored for up to nine months.

Read More

STAT+: The biotech scorecard for the third quarter: 18 stock-moving events to watch

By Adam Feuerstein

Ryan Pierse/Getty Images

There's plenty to watch out for in the months ahead, including a readout from Alnylam Pharmaceuticals and another from Karuna Therapeutics.

Read More

STAT+: The Q3 health tech tracker: 11 key industry events and debates to watch

By Mohana Ravindranath and Katie Palmer

Photo by KEREM YUCEL/AFP via Getty Images

STAT has your guide to the health tech industry events, deals, and discussions to watch in the third quarter.

Read More

Opinion: The accuracy of pulse oximeters shouldn't depend on a person's skin color

By A. Ian Wong

Adobe

Pulse oximeters are less accurate when measuring the blood oxygen level of people with darker skin. Makers need to fix that problem.

Read More

STAT+: Anebulo Pharma says study supports development of its pill as an antidote for cannabis intoxication

By Adam Feuerstein

Jessica Rinaldi/The Boston Globe

The company, based in Austin, Texas, believes its medicine could be used as a potential antidote for cannabis intoxication.

Read More

Tuesday, July 5, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments